From: Evaluation of the safety and effectiveness of tubal inflammatory drugs in patients with incomplete tubal obstruction after four-dimensional hysterosalpingo-contrast-sonography examination
Group
n
pregnancy
P
Yes
No
E-group
82
22 (26.8)*
60 (73.2)
0.032
C-group
111
16 (14.4)
95 (85.6)